Tissue sampling could originally only establish the diagnosis of lung cancer, but now sufficient tissue sampling is needed for next generation sequencing for epidermal growth factor receptor (EGFR), anaplastic lymphoma kinase (ALK), ‐etc‐. The gene discussed is EGFR; the disease is lung cancer.